Takeda and AWS accelerate COVID-19 research push
The public cloud has become a key facilitator for meeting new demands as a result of the coronavirus pandemic. This has been especially true for the pharmaceutical sector in which multibillion-dollar companies race to cultivate therapies to treat complications and comorbidities associated with COVID-19, as well as vaccines. Takeda Pharmaceutical, which make medicines that treat…